Stratatech Technologies, now a Mallinckrodt company, is a leading regenerative medicine and skin tissue development company based in Madison, WI. With a rich heritage spanning over 155 years, Stratatech is known for its commitment to quality, integrity, and service. Their core strengths lie in their specialty generics, innovative research, and advanced drug delivery technologies. Through strategic partnerships and a patient-centric approach, Stratatech aims to revolutionize the field of regenerative medicine and provide effective solutions for patients in need.
As a Mallinckrodt company, Stratatech continues to build on its legacy by focusing on community outreach, business ethics, and diversity and inclusion. With a strong emphasis on scientific research and development, Stratatech's pipeline includes groundbreaking products like StrataGraft regenerative medicine skin tissue and ExpressGraft genetically modified human skin substitute. Committed to making a positive impact, Stratatech is dedicated to improving patient outcomes and advancing the field of regenerative medicine.
Generated from the website